Immunological pathways such as those associated with cytokine signaling and toll-like receptor signaling were negatively enriched in TBM when compared with OI controls, with IL-1 and TNF being significantly downregulated (Fig. 2b and Supplementary Data 6). The gene discussed is TNF; the disease is osteogenesis imperfecta.